Olympus Corporation
VC Fund
Tokyo, Japan
Olympus Corporation is a VC fund in Tokyo focused on Health Care and Medical Device. Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates in four segments: Medical, Scientific, Imaging, and Others. The medical business segment provides endoscopy systems comprising videoscopes, video processors, light sources, and liquid crystal display panels; peripheral equipment such asimage recording devices, endoscope cleaning systems, and sterilization systems; surgical video endoscopy systems and peripheral devices for endoscopic surgery, electrosurgical knives and more.; and endoscopic devices for various diagnostic and treatment procedures, including biopsy forceps, high-frequency polypectomy snares, grasping forceps, stone retrieval and lithotriptor baskets, and hemostasis accessories.The scientific solutions business segment offers upright and polarizing microscopes, inverted microscopes, laser confocal microscopes, box-type fluorescence imaging devices, stereo microscopes, fluorescence macro microscopes, microscope digital cameras, imaging software, bio-imaging systems, and virtual slide systems; and metallurgical microscopes, semiconductor inspection microscopes, laser and measuring microscopes, microscopic 3D measurement systems, industrial videoscopes and fiberscopes, industrial rigid scopes, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, X-ray diffraction analyzers, and peripheral equipment. The imaging business segment offers digital single-lens cameras, compact digital cameras and related products, digital camera lens barrels, and optical components as well as IC recorders and binoculars. The Others Business segment manufactures biomedical materials as well as conducts system development and other business activities.Olympus Corporation was founded by Takeshi Yamashita in October 1919 and is headquartered in Tokyo, Japan.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Olympus Corporation invests in
Stages Olympus Corporation invests in
Countries Olympus Corporation invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 4 (80%)
- Medical Device 4 (80%)
- Video 1 (20%)
- Content 1 (20%)
- Medical 1 (20%)
Stage
- Series A 2 (40%)
- Series D 2 (40%)
- Venture - Series Unknown 1 (20%)
Country
- United States 4 (80%)
- Japan 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andre Roggan
Executive Managing Director & Chairman of the Board
|
Executive Managing Director & Chairman of the Board | Total investments: 0 | Find email | |
|
Chikashi Takeda
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
Gabriela Kaynor
Chief Strategy Officer (CSO)/ Executive Officer
|
Chief Strategy Officer (CSO)/ Executive Officer | Total investments: 1 | Find email | |
Kenneth Olsen
Global Associate General Counsel, Regulatory Law
|
Global Associate General Counsel, Regulatory Law | Total investments: 0 | Find email | |
Michael Speiser
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Neptune Medical
|
Neptune Medical is a venture capital funded medical device start-up, located in the Silicon Valley town of Burlingame. they develop, manufacture, and commercialize high-volume, high clinical utility, single use medical devices for gastroenterology. they believe that our patent-pending technology is foundational and will have a broad impact acrossmultiple additional clinical areas, including cardiovascular and flexible robotic surgery procedures. | $97M / Series D / Aug 15, 2024 | |
NeuSpera Medical
|
NeuSpera Medical develops implantable medical device technology to treat chronic illnesses through minimally invasive solutions. NeuSpera focuses on bioelectronic medicine and has developed ultra-miniaturized implants using their proprietary Mid-Field Powering technology. This technology allows the implants to be powered externally, enabling deeperand more reliable neuromodulation treatments for conditions like Urinary Urgency Incontinence (UUI) and chronic peripheral nerve pain | $23M / Series D / Jul 15, 2024 | |
Eximis Surgical
|
Eximis Surgical is developing an enabling technology that allows surgeons to quickly remove large specimens through small incisions. Its technology uses RF energized cutting wires temporarily held in place within a containment bag. It was founded in 2014 and headquartered in Louisville, Colorado. | $15.3M / Venture - Series Unknown / Apr 24, 2023 | |
Virgo
|
Virgo provides a user friendly, low cost, HIPAA compliant cloud video platform for GI endoscopy. Prior to Virgo, gastroenterologists had to use DVD's and thumb drives to capture video from procedures such as colonoscopies and upper endoscopies. Virgo simplifies video capture and consumption for GI's, enabling them to use video for patientcare, quality improvement, research, training, and more. | $8M / Series A / Jan 05, 2022 | |
LPIXEL
|
LPIXEL, a spin-out venture from the University of Tokyo, is a leader in advanced image analysis software and systems tailored to life science research. With strong emphasis on integrating top-tier technologies to its services and strong dedication to maximize research efficiency. LPIXEL aims to bring innovation to the world of research. | $425.2M / Series A / Oct 28, 2018 |
Co-Investors
Questa Capital Management
2 deals together
Action Potential Venture Capital
1 deal together
American Gastroenterological Association
1 deal together
Canon Medical Systems
1 deal together
CEJ Capital
1 deal together
Cyberdyne
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Olympus Corporation invest in?
Olympus Corporation invests primarily in Health Care, Medical Device and Video startups, most often at Series A and Series D stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Olympus Corporation?
Public channels for Olympus Corporation include the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Olympus Corporation?
The team at Olympus Corporation includes Andre Roggan (Executive Managing Director & Chairman of the Board), Chikashi Takeda (Chief Financial Officer) and Gabriela Kaynor (Chief Strategy Officer (CSO)/ Executive Officer), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
